Cargando…
Fetal Exposure to Altered Amniotic Fluid Glucose, Insulin, and Insulin-Like Growth Factor–Binding Protein 1 Occurs Before Screening for Gestational Diabetes Mellitus
OBJECTIVE: We explored the possibility that perturbations in amniotic fluid glucose, insulin, and insulin-like growth factor–binding protein 1(IGFBP1) and/or metabolic acids exist before routine screening for GDM. RESEARCH DESIGN AND METHODS: We selected consenting mother-infant pairs (n = 408) who...
Autores principales: | Tisi, Daniel K., Burns, David H., Luskey, Gary W., Koski, Kristine G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005441/ https://www.ncbi.nlm.nih.gov/pubmed/20855548 http://dx.doi.org/10.2337/dc10-0607 |
Ejemplares similares
-
Use of Near-Infrared Spectroscopic Analysis of Second Trimester Amniotic Fluid to Assess Preterm Births
por: Power, Kristin M., et al.
Publicado: (2011) -
Effects of insulin on placental, fetal and maternal outcomes in gestational diabetes mellitus
por: Arshad, Rabia, et al.
Publicado: (2014) -
Serum and Amniotic Fluid Metabolic Profile Changes in Response to Gestational Diabetes Mellitus and the Association with Maternal–Fetal Outcomes
por: Zhou, Yalin, et al.
Publicado: (2021) -
Insulin secretion and insulin resistance in Korean women with gestational diabetes mellitus and impaired glucose tolerance
por: Yang, Sae Jeong, et al.
Publicado: (2013) -
Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications?
por: Stein, Roland Gregor, et al.
Publicado: (2014)